Evidence map›Paper›PMID 37603123›Full record

ArticleEJNMMI physics2023

Imaging of

Monika Kvassheim, Anna Julie Kjøl Tornes, Asta Juzeniene, Caroline Stokke, Mona-Elisabeth R Revheim

Open access · goldAbstract read
In one paragraph

Article in EJNMMI physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Therapeutic evaluation of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  4. EJNMMI radiopharmacy and chemistry · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Monika KvassheimDivision of Radiology and Nuclear Medicine, Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway. mokvas@ous-hf.no.ORCID http://orcid.org/0000-0001-7985-1980
Anna Julie Kjøl TornesFaculty of Medicine, University of Oslo, Oslo, Norway.
Asta JuzenieneDepartment of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Caroline StokkeDivision of Radiology and Nuclear Medicine, Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.
Mona-Elisabeth R RevheimFaculty of Medicine, University of Oslo, Oslo, Norway.
Oslo University Hospital · NO

Funding

Helse Sør-Øst RHF 2020028The Norwegian Research Council 329538
6 · The paper itself

Abstract

introduction

methodsA mouse phantom with

resultsFour volumes in the mouse phantom of ~ 300 μl with 246-303 kBq/ml of

conclusionAlthough the preclinical scanner should be used preferentially in biodistribution studies in mice, the clinical SPECT/CT confirmed uptake in small volumes (e.g. ~ 300 μl volume with ~ 250 kBq/ml). Regardless of system, the resolution and sensitivity limits should be carefully determined, otherwise false negative or too low uptakes can be wrongly interpreted.

Indexed as

212PbAlphaImagingLead-212PhantomPreclinicalSPECTTherapy

Identifiers

PMID37603123
PMCPMC10442031
OpenAlexW4386019305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.